Literature DB >> 12782287

Transcriptional repression of cyclin-dependent kinase inhibitor p21 gene by phospholipase D1 and D2.

Hyun Jin Kwun1, Jae Hwa Lee, Do Sik Min, Kyung Lib Jang.   

Abstract

Phospholipase D (PLD) is known to stimulate cell cycle progression and to transform murine fibroblast cells into tumorigenic forms, although the precise mechanisms are not elucidated. In this report, we demonstrated that both PLD1 and PLD2 repressed expression of cyclin-dependent kinase inhibitor p21 gene in an additive manner. The phospholipase activity of PLDs was important for the effect. PLD1 repressed the p21 promoter by decreasing the level of p53, whereas PLD2 via a p53-independent pathway through modulating Sp1 activity. Taken together, we suggest that PLD isozymes stimulate cell growth by repressing expression of p21 gene, which may ultimately lead to carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12782287     DOI: 10.1016/s0014-5793(03)00446-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

Review 1.  The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).

Authors:  Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

2.  High Expression of PhospholipaseD2 Induced by Hypoxia Promotes Proliferation of Colon Cancer Cells through Activating NF- κ Bp65 Signaling Pathway.

Authors:  Maoxi Liu; Kunli Du; Bo Jiang; Xingye Wu
Journal:  Pathol Oncol Res       Date:  2018-08-08       Impact factor: 3.201

3.  Mutation of Y179 on phospholipase D2 (PLD2) upregulates DNA synthesis in a PI3K-and Akt-dependent manner.

Authors:  Mauricio Di Fulvio; Kathleen Frondorf; Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2007-10-13       Impact factor: 4.315

4.  Macrophage migration arrest due to a winning balance of Rac2/Sp1 repression over β-catenin-induced PLD expression.

Authors:  Francis J Speranza; Madhu Mahankali; Julian Gomez-Cambronero
Journal:  J Leukoc Biol       Date:  2013-07-29       Impact factor: 4.962

Review 5.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

6.  Overexpression of phospholipase D prevents actinomycin D-induced apoptosis through potentiation of phosphoinositide 3-kinase signalling pathways in Chinese-hamster ovary cells.

Authors:  Momoko Yamada; Yoshiko Banno; Yoh Takuwa; Masahiro Koda; Akira Hara; Yoshinori Nozawa
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.